327 related articles for article (PubMed ID: 27814616)
21. Role of microglia in glioma biology.
Badie B; Schartner J
Microsc Res Tech; 2001 Jul; 54(2):106-13. PubMed ID: 11455617
[TBL] [Abstract][Full Text] [Related]
22. Microglia function in brain tumors.
Watters JJ; Schartner JM; Badie B
J Neurosci Res; 2005 Aug; 81(3):447-55. PubMed ID: 15959903
[TBL] [Abstract][Full Text] [Related]
23. [The immunosuppressive microenvironment of malignant gliomas].
Borisov KE; Sakaeva DD
Arkh Patol; 2015; 77(6):54-63. PubMed ID: 26841651
[TBL] [Abstract][Full Text] [Related]
24. CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma.
Tanaka S; Ohgidani M; Hata N; Inamine S; Sagata N; Shirouzu N; Mukae N; Suzuki SO; Hamasaki H; Hatae R; Sangatsuda Y; Fujioka Y; Takigawa K; Funakoshi Y; Iwaki T; Hosoi M; Iihara K; Mizoguchi M; Kato TA
Front Immunol; 2021; 12():670131. PubMed ID: 34267749
[TBL] [Abstract][Full Text] [Related]
25. Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies.
da Fonseca AC; Badie B
Clin Dev Immunol; 2013; 2013():264124. PubMed ID: 23864876
[TBL] [Abstract][Full Text] [Related]
26. CNS macrophages and peripheral myeloid cells in brain tumours.
Glass R; Synowitz M
Acta Neuropathol; 2014 Sep; 128(3):347-62. PubMed ID: 24722970
[TBL] [Abstract][Full Text] [Related]
27. Exploiting Microglial Functions for the Treatment of Glioblastoma.
Dello Russo C; Lisi L; Tentori L; Navarra P; Graziani G; Combs CK
Curr Cancer Drug Targets; 2017; 17(3):267-281. PubMed ID: 27528361
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions.
Liu J; Piranlioglu R; Ye F; Shu K; Lei T; Nakashima H
Front Cell Infect Microbiol; 2023; 13():1141034. PubMed ID: 37234776
[TBL] [Abstract][Full Text] [Related]
29. The Dynamics of Interactions Among Immune and Glioblastoma Cells.
Eder K; Kalman B
Neuromolecular Med; 2015 Dec; 17(4):335-52. PubMed ID: 26224516
[TBL] [Abstract][Full Text] [Related]
30. Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment.
Dumas AA; Pomella N; Rosser G; Guglielmi L; Vinel C; Millner TO; Rees J; Aley N; Sheer D; Wei J; Marisetty A; Heimberger AB; Bowman RL; Brandner S; Joyce JA; Marino S
EMBO J; 2020 Aug; 39(15):e103790. PubMed ID: 32567735
[TBL] [Abstract][Full Text] [Related]
31. CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages.
Levy A; Blacher E; Vaknine H; Lund FE; Stein R; Mayo L
Neuro Oncol; 2012 Aug; 14(8):1037-49. PubMed ID: 22700727
[TBL] [Abstract][Full Text] [Related]
32. New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs.
Lakshmanachetty S; Cruz-Cruz J; Hoffmeyer E; Cole AP; Mitra SS
Cells; 2021 Apr; 10(4):. PubMed ID: 33919732
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of Aquaporin-1 mediates a microglial phenotype switch affecting glioma growth.
Hu F; Huang Y; Semtner M; Zhao K; Tan Z; Dzaye O; Kettenmann H; Shu K; Lei T
Exp Cell Res; 2020 Nov; 396(2):112323. PubMed ID: 33058832
[TBL] [Abstract][Full Text] [Related]
34. Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.
McFarland BC; Marks MP; Rowse AL; Fehling SC; Gerigk M; Qin H; Benveniste EN
Oncotarget; 2016 Apr; 7(15):20621-35. PubMed ID: 26967393
[TBL] [Abstract][Full Text] [Related]
35. EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment.
Yin Y; Qiu S; Li X; Huang B; Xu Y; Peng Y
J Neuroinflammation; 2017 Nov; 14(1):220. PubMed ID: 29132376
[TBL] [Abstract][Full Text] [Related]
36. Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression.
Ellert-Miklaszewska A; Wisniewski P; Kijewska M; Gajdanowicz P; Pszczolkowska D; Przanowski P; Dabrowski M; Maleszewska M; Kaminska B
Oncogene; 2016 Dec; 35(50):6366-6377. PubMed ID: 27041573
[TBL] [Abstract][Full Text] [Related]
37. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.
Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Kristensen BW
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):185-206. PubMed ID: 28767130
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages.
Zhang I; Alizadeh D; Liang J; Zhang L; Gao H; Song Y; Ren H; Ouyang M; Wu X; D'Apuzzo M; Badie B
PLoS One; 2016; 11(12):e0165118. PubMed ID: 27936099
[TBL] [Abstract][Full Text] [Related]
39. The potential for genetically altered microglia to influence glioma treatment.
Li W; Holsinger RM; Kruse CA; Flügel A; Graeber MB
CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):750-62. PubMed ID: 24047526
[TBL] [Abstract][Full Text] [Related]
40. SorLA restricts TNFα release from microglia to shape a glioma-supportive brain microenvironment.
Kaminska P; Ovesen PL; Jakiel M; Obrebski T; Schmidt V; Draminski M; Bilska AG; Bieniek M; Anink J; Paterczyk B; Jensen AMG; Piatek S; Andersen OM; Aronica E; Willnow TE; Kaminska B; Dabrowski MJ; Malik AR
EMBO Rep; 2024 May; 25(5):2278-2305. PubMed ID: 38499808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
